Irbesartan and Hydrochlorothiazide Dispersible Tablets
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20080730
Indications:
Used to treat primary hypertension.
Administration:
One tablet once daily. Take on an empty stomach or with food. Used to treat patients whose blood pressure is not effectively controlled by irbesartan or hydrochlorothiazide alone.
It is recommended that patients adjust the dosage of the single component (i.e., irbesartan or hydrochlorothiazide).
This combination is used for patients whose blood pressure is not effectively controlled by hydrochlorothiazide or 150mg of irbesartan alone.
A daily dose greater than 300mg of irbesartan/25mg of hydrochlorothiazide is not recommended. If necessary, this product can be used in combination with other antihypertensive drugs.
Specifications:
150mg/12.5mg × 14 tablets
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Email: marcos.yuan@wangao.com.cn
Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province
Mobile Version QR Code
WeChat Official Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.